Low
₹115.55
High
₹130.00
| Previous Close | ₹118.95 |
|---|---|
| Day's Range | ₹115.55 - ₹130.00 |
| Open | ₹130.00 |
| 52 Week Range | ₹107.50 - ₹292.95 |
| Volume | 2,400 |
| Market Cap | ₹0.00 |
| Trade Value ( ₹ in Lacs) | 2.90 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -3.64 |
| P/E Ratio | 110.57 |
| Book Value(₹) | 3.02 |
| PAT Margin (%) | 4.01 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 10.96 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 444.13 | 104.98 |
| Expenses | N/A | 0.0 |
| PBT | 32.22 | 26.03 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 19.0 | 17.94 |
| Founded | 2019 |
|---|---|
| Managing Director | Narendra Singh Tanwar |
| NSE Symbol | MAITREYA |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,55,993.61 | 1,900.50 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,40,249.06 | 9,050.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,91,134.85 | 5,025.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,26,609.58 | 8,805.50 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,18,603.21 | 1,189.00 | 835.50 - 835.50 |
| Cipla Ltd. | 1,14,707.82 | 1,419.90 | 1,165.70 - 1,165.70 |
| Lenskart Solutions Ltd. | 1,11,246.02 | 642.00 | 0.00 - 0.00 |
| Manipal Health Enterprises Ltd. | 1,04,901.33 | 798.90 | 625.45 - 625.45 |
| Laurus Labs Ltd. | 1,03,739.95 | 1,920.00 | 823.10 - 823.10 |
| Mankind Pharma Ltd. | 99,821.13 | 2,417.00 | 1,909.70 - 1,909.70 |
No Records Found
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aanjaay Industries has informed that a meeting of the Board of Directors of the Company is scheduled to be held on 02nd September 2026 at the Corporate Office of the Company situated at Chennai, to consider and approve the following business: 1. To approve Director’s Report and Corporate Governance Report for the financial year ended 31st March 2026. 2. To approve closure of Register of Members and Share Transfer Books of the Company for Annual General Meeting (AGM) purpose. 3. To approve the Cut-off date to record the entitlement of shareholders to cast their votes for the Annual General Meeting (AGM). 4. To fix the Date, Time and Venue to convene the Annual General meeting of the Company & the draft Notice calling the Annual General Meeting (AGM). 5. To consider and approve appointment of scrutinizer for Annual General Meeting (AGM) purpose. 6. To consider and recommend the re-appointment of Kuniamuthur Nanjappan Anand (DIN: 03230186), Director of the Company, who retires by rotation at the ensuing Annual General Meeting 7. To consider and approve the appointment of Internal Auditors of the Company for the financial year 2026-2027. 8. To recommend the appointment of Moonam Kapoor (DIN: 09278005) as Director of the Company. 9. To recommend the appointment of Secretarial Auditor of the Company for the financial year 2026-2027 to 2030-2031. 10. Any other agenda with permission of chair.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Maitreya Medicare Ltd. is ₹118.95 as of 2026-08-27.
The market capitalisation of Maitreya Medicare Ltd. is ₹80.60 as of 2026-08-27.
The 1-year return of Maitreya Medicare Ltd. is -145.05% as of 2026-08-27.
The P/E ratio of Maitreya Medicare Ltd. is 110.57 as of 2026-08-28.
The 52-week high and low of Maitreya Medicare Ltd. are ₹292.95 and ₹107.50, respectively, as of 2026-08-27.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.